Favorable impact of the t(9;11) in childhood acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

http://www.wikidata.org/entity/Q34522766

about

How I treat pediatric acute myeloid leukemia Childhood acute myeloid leukaemia Current Management of Childhood Acute Myeloid Leukemia.Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners Recent advances in the treatment of infant acute myeloid leukemia.Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.Treatment of childhood acute myeloid leukemia.Interactive diagnostics in the indication to allogeneic SCT in AML.MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.MLL-SEPTIN gene fusions in hematological malignancies.MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.A pipeline with multiplex reverse transcription polymerase chain reaction and microarray for screening of chromosomal translocations in leukemia Molecular identification of a new splicing variant of the MLL - MLLT11 fusion transcript in an adult with acute myeloid leukemia and t(1;11)(q21;q23).Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution.Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia.Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report.Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic Acute myeloid leukemia Acute Myeloid Leukemia High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome

P2860

Q26992280-D2E771F9-8058-4A71-B635-09CF4B02B323 Q27005960-6BCADFB1-E711-4C3A-A508-C74DA7E44532 Q30244036-D368CA08-F2DE-49BE-9894-8B25D1673D64 Q34080807-B9F8A65D-9747-4A9E-916B-1C054DC80758 Q34620470-1D552483-5F48-4C64-9206-CA2E45C1FAB8 Q35152603-67D349EA-CE3C-4610-848E-2CCEA9C2067D Q35209900-CF9D4EAA-D2A1-42A6-88DD-9077B4A01ED5 Q35887901-92D79F63-0AD0-40D3-9D99-E3490077F736 Q35921471-E2F93198-2254-4483-9067-4D6237B45D0F Q36153422-AE8DE985-FC60-49FC-AEE8-00B4B7607F0E Q36284532-EB12182F-153D-4AC6-8311-1A5AD46B3DDC Q37442649-1E21A46C-3D0D-4749-ACC6-C8BC41DBE508 Q37633585-50D99578-B075-4CA8-91ED-749B78DDCB4F Q37874929-272DB2BD-D962-41D5-A63C-D0DFEF4231CE Q37895709-2845E69D-C53E-43D5-9549-FF3627F66351 Q38110943-B8D4C93D-F17D-4BA6-BF30-BF3970FD652D Q38196743-A0CEDC56-C535-4EFE-AC63-72197A4ADA21 Q40149789-435B8B2B-F294-4B51-93FF-12CBCAF6C192 Q40373597-7D648119-2221-456C-BEEA-39FE63CA9938 Q41133881-2A1842EC-C41E-42EA-8632-0B2322AB82E7 Q42127851-AE98CD94-2060-44E0-942A-5BD37EECBF25 Q42661587-7ECA3388-B312-45E3-8094-416AAC6419D6 Q44331222-D0C3FC8B-69C2-47E1-B54D-C3423D0F8DD0 Q44503960-64E765FA-2B0A-4FEF-8DB5-8980556D1133 Q46099641-F398970E-3EA6-4339-9CDC-0FC5C88187E5 Q46169481-18A07F6E-A6AE-47B9-B902-5944A047F955 Q46424987-DBDA4D43-099C-4F41-B127-9DFCE06A0C5D Q46681659-C3D2B482-7AF7-402B-9C37-AA7FAB752795 Q46817257-AC0B0F5C-E652-4F24-932F-C7D20086D58B Q47857157-2DB1B131-6A4A-4A8F-A056-564FD5FAAC85 Q58459171-A95AE0F9-A585-43B7-93C1-C1D6F720CE72 Q58481761-828DFD73-F6A9-46B0-9AD2-44D6A82AC242 Q58481811-515840D4-FE8B-4135-A5B9-62FA7BAADE0F Q58492940-BD769886-AB8B-404A-B0E3-6EAC2F537580

P2860

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

http://www.wikidata.org/entity/Q34522766

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Favorable impact of the t

@nl

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

@ast

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

@en

type

label

Favorable impact of the t

@nl

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

@ast

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

@en

prefLabel

Favorable impact of the t

@nl

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

@ast

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

@en

P1433

Q34522766-EF3942E2-2F82-4889-B67A-6CA383C559DE

P1476

Q34522766-81324962-4A5D-422D-800A-3D6D71D63EFB

P2093

Q34522766-06193489-4CC2-4C00-8E17-36FE457A2DBC

Q34522766-5E4C7040-3CC4-49FD-92EE-D7F334E7D4D9

Q34522766-6E4B2E5D-5893-40BC-A2D4-CCF0951CBF56

Q34522766-8920C505-EBD7-469E-AB35-94656004791A

Q34522766-BFF643B7-8CE3-4EF9-A96D-1D4A96134690

Q34522766-C5B153D4-16AE-45F9-AA8D-8BDFBDF2BF7F

Q34522766-DB20C67F-9206-4D92-B070-7B3F27824C2D

Q34522766-E3616F66-3CED-45B6-83FA-6A4E4ECE14D4

Q34522766-EB1E5EBF-5BDB-4EE2-A7EB-86766A35CCA8

P304

Q34522766-EF6E3241-294D-41DC-A463-89C0DB62FEA3

P31

Q34522766-4A2F3623-7413-47BF-B196-79F5BA3AC760

P356

Q34522766-D40E9CF9-6254-4687-AA5B-94B459D17583

P407

Q34522766-342F7B39-A736-4B57-B846-105AED3BB05A

P433

Q34522766-03EF4B5A-29FF-4A6D-9F4A-8912C3B9C941

P478

Q34522766-A20EEF15-566E-4B42-BE50-50BFD5308617

P50

Q34522766-16F17CC3-088F-49CA-94D9-01D315AD550B

P577

Q34522766-4A6C5B83-0405-42D7-960E-547C7F2E163D

P698

Q34522766-2B533AD3-B71F-47C3-8E97-8E3153A33201

P921

Q34522766-E29E46D3-34EA-4A48-AECC-DCC76B6A9D42

P356

JCO.2002.08.400

P1433

Journal of Clinical Oncology

P1476

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

@en

P2093

Bassem I Razzouk

http://www.w3.org/2001/XMLSchema#string

Deo Kumar Srivastava

http://www.w3.org/2001/XMLSchema#string

Frederick G Behm

http://www.w3.org/2001/XMLSchema#string

James R Downing

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Rubnitz

http://www.w3.org/2001/XMLSchema#string

Raul C Ribeiro

http://www.w3.org/2001/XMLSchema#string

Sheila A Shurtleff

http://www.w3.org/2001/XMLSchema#string

Susana C Raimondi

http://www.w3.org/2001/XMLSchema#string

Xin Tong

http://www.w3.org/2001/XMLSchema#string

P304

2302-2309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2002.08.400

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11981001

http://www.w3.org/2001/XMLSchema#string

P921